| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $3.1M | -32.4% |
| R&D Expense | $2.1M | -9.0% |
| SG&A Expense | $8.5M | +1.4% |
| Operating Income | -$9.4M | -18.7% |
| Pre-tax Income | -$10.6M | -38.5% |
| Income Tax | $8K | +157.9% |
| Net Income | -$12.5M | -64.2% |
| EPS (Basic) | -$11.36 | -961.7% |
| EPS (Diluted) | -$11.36 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2.8M | -11.4% |
| Accounts Receivable | $333K | -51.5% |
| Current Assets | $4.7M | -0.7% |
| Total Assets | $8.6M | +9.0% |
| Current Liabilities | $4.2M | +53.5% |
| Long-term Debt | $952K | -0.2% |
| Total Liabilities | $5.4M | +36.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$8.9M | -13.6% |
| Capital Expenditures | $15K | +211.4% |
| Investing Cash Flow | -$907K | -125.7% |
| Financing Cash Flow | $9.5M | -7.1% |
| Free Cash Flow | -$8.9M | -13.7% |
| -961.7% |
| Stockholders' Equity |
| $3.0M |
| -19.3% |